相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury
Soo Ryeong Jeong et al.
EXPERIMENTAL NEUROLOGY (2012)
The HGF Receptor/Met Tyrosine Kinase Is a Key Regulator of Dendritic Cell Migration in Skin Immunity
Jea-Hyun Baek et al.
JOURNAL OF IMMUNOLOGY (2012)
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis
Andre Michael Mueller et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats
Milena Z. Adzemovic et al.
PLOS ONE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
CCL5 induces a pro-inflammatory profile in microglia in vitro
Jelena Skuljec et al.
CELLULAR IMMUNOLOGY (2011)
Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients
Elizabeth R. Comini-Frota et al.
CNS DRUGS (2011)
Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis
Andrea Rottlaender et al.
IMMUNOLOGY (2011)
The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
Ellen Iacobaeus et al.
PLOS ONE (2011)
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis
Giuseppe Scalabrino et al.
BRAIN RESEARCH (2010)
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis
J. Ockinger et al.
GENES AND IMMUNITY (2010)
Enhancement of Chemokine Expression by Interferon Beta Therapy in Patients With Multiple Sclerosis
Sabine Cepok et al.
ARCHIVES OF NEUROLOGY (2009)
Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation
F. Sellebjerg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Role and Therapeutic Potential of VEGF in the Nervous System
Carmen Ruiz De Almodovar et al.
PHYSIOLOGICAL REVIEWS (2009)
Epidermal Growth Factor Induces the Progeny of Subventricular Zone Type B Cells to Migrate and Differentiate into Oligodendrocytes
Oscar Gonzalez-Perez et al.
STEM CELLS (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients
Paola Sarchielli et al.
NEUROSCIENCE LETTERS (2008)
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
Adam Szczucinski et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors
Yi Wei Zhang et al.
STEM CELLS AND DEVELOPMENT (2006)
An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians
Matthew J. Bugeja et al.
BMC MEDICAL GENETICS (2006)
IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles
C. Malmestrom et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
The expression and function of chemokines involved in CNS inflammation
EE Ubogu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients
H Bartosik-Psujek et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway
PH Lalive et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo
AM Butt et al.
EXPERIMENTAL NEUROLOGY (2005)
Involvement of beta-chemokines in the development of inflammatory demyelination
Ileana Banisor et al.
JOURNAL OF NEUROINFLAMMATION (2005)
The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease
H Bartosik-Psujek et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
K Narikawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia
H Amano et al.
JOURNAL OF IMMUNOLOGY (2004)
VEGF-mediated inflammation precedes angiogenesis in adult brain
SD Croll et al.
EXPERIMENTAL NEUROLOGY (2004)
Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse
H Bartosik-Psujek et al.
EUROPEAN NEUROLOGY (2004)
Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult
U Graumann et al.
BRAIN PATHOLOGY (2003)
Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis
AR Glabinski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro
L Magy et al.
EXPERIMENTAL NEUROLOGY (2003)
The chemokine system in neuroinflammation: An update
RM Ransohoff
JOURNAL OF INFECTIOUS DISEASES (2002)
Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation
RJ Carmody et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats
MA Proescholdt et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Hepatocyte growth factor in cerebrospinal fluid in neurologic disease
Y Tsuboi et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease
E Scarpini et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Interferon β-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis
C Iarlori et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Chemokines in autoimmune disease
N Godessart et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Cytokine and IL-12 receptor mRNA discriminate between different clinical subtypes in multiple sclerosis
AHH van Boxel-Dezaire et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis
TL Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo
DR Goddard et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis
SM Ibrahim et al.
BRAIN (2001)
Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
E Sindern et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions
MA Kern et al.
CYTOKINE (2001)
Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling
T Misu et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
Experimental autoimmune encephalomyelitis on the SJL mouse:: Effect of γδ T cell depletion on chemokine and chemokine receptor expression in the central nervous system
AJ Rajan et al.
JOURNAL OF IMMUNOLOGY (2000)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)
Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis - Overexpression of chemokine receptor CCR5
YCQ Zang et al.
BRAIN (2000)
分享论文
